CoChat

Thyroglobulin measurement in the management of patients with differentiated thyroid cancer

Algeciras-Schimnich, Alicia · 2018 · Critical Reviews in Clinical Laboratory Sciences

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

Abstract

The post-operative management of patients with differentiated thyroid carcinoma (DTC) relies on serial measurements of serum thyroglobulin. Current methodologies for thyroglobulin quantitation vary in their analytical and clinical performance. For years, thyroglobulin radioimmunoassays (RIA) and immunometric assays (IMA) have been used despite analytical interferences from anti-thyroglobulin autoantibodies (TgAb) as well as heterophile antibodies (HAb). TgAb interference limits Tg utility as a tumor marker in ∼30% of TgAb-positive patients. Consequently, additional studies are necessary to rule out persistent or recurrent disease in these patients. Recently, thyroglobulin mass spectrometry assays have been introduced as a solution to the interference problems observed in immunoassays. However, their analytical sensitivity is inferior to the high sensitivity immunoassays. The aims of this review are to: (i) review current thyroglobulin assays; (ii) discuss technical limitations of each assay; and (iii) discuss the clinical uses of thyroglobulin in serum and fine-needle aspirate biopsy washouts for the management of DTC patients. An understanding of the technical advantages and disadvantages of Tg assays is critical for clinicians and laboratorians to effectively use and interpret this test in the management of DTC patients.

Overview

Integrity signals

Registry

Crossref · 10.1080/10408363.2018.1450830

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 100 references

Research works printed but not linked: 6

  1. Feldt-Rasmussen U, 1996, Ann Biol Clin, 54, 337
  2. Feldt-Rasmussen U, 1996, Ann Biol Clin, 54, 343
  3. Ozata M, 1994, J Clin Endocrinol Metab, 79, 98
  4. Spencer CA, 1998, J Clin Endocrinol Metab, 83, 1121
  5. 10.1210/jcem.87.2.8182 · doi:10.1210/jcem.87.2.8182 · Paper page
  6. Pacini F, 1992, J Clin Endocrinol Metab, 74, 1401

Cited by

See all 63

Metadata

Authors
Algeciras-Schimnich, A.
Affiliations
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Venue
Critical Reviews in Clinical Laboratory Sciences
Published
2018-03-16
Volume
55
Issue
3
Pages
205-218
ISSN
  • 1040-8363 (ISSN-L)
  • 1549-781X
OpenAlex
W2790937305
Cited by
63
References
100
Citations by year
2026: 5 · 2025: 9 · 2024: 6 · 2023: 11 · 2022: 14 · 2021: 8 · 2020: 8 · 2019: 2
FWCI
0.69
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Clinical Laboratory Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
thyroglobulin, differentiated thyroid cancer, thyroglobulin antibodies, heterophile antibodies, assay interference, radioimmunoassay, immunometric assay, tumor markers, postoperative monitoring, recurrence
MeSH terms
Autoantibodies, Humans, Thyroglobulin, Thyroid Neoplasms, Biomarkers, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thyroglobulin measurement in the management of patients with differentiated thyroid cancer. https://app.cochat.ai/papers/10.1080/10408363.2018.1450830
The paper
Algeciras-Schimnich, A. (2018). Thyroglobulin measurement in the management of patients with differentiated thyroid cancer. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.1080/10408363.2018.1450830

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.